Wataru Atsumi

Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation

Koshiro Kanaoka, Kenji Onoue, Satoshi Terasaki et al. · Circulation · 2022 · 59 citations · Full text

Medicine, Cardiology, Internal Medicine +13

Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study

Shigemasa Tani, Tsukasa Yagi, Wataru Atsumi et al. · Cardiovascular Diabetology · 2017 · 56 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Association of plasminogen activator inhibitor-1 and low-density lipoprotein heterogeneity as a risk factor of atherosclerotic cardiovascular disease with triglyceride metabolic disorder

Kiyoshi Iida, Shigemasa Tani, Wataru Atsumi et al. · Coronary Artery Disease · 2017 · 18 citations

Medicine, Biochemistry, Cardiology +15

Impact of Adding Eicosapentaenoic Acid to Statin Therapy on Plasma Pentraxin 3 Level in Patients with Stable Coronary Artery Disease: A 6-Month, Randomized Controlled Study

Shigemasa Tani, Ken Nagao, Tsukasa Yagi et al. · American Journal of Cardiovascular Drugs · 2016 · 14 citations

Medicine, Cardiology, Pharmacology +12

The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy

Shigemasa Tani, Ken Nagao, Kenji Kawauchi et al. · American Journal of Cardiovascular Drugs · 2017 · 12 citations

Medicine, Cardiology, Pharmacology +14